Published in Clin Vaccine Immunol on April 22, 2009
Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia. Antimicrob Agents Chemother (2011) 0.92
A Novel Innate Immune-Enhancement Strategy Combined with IVIG Rescues Mice from Fatal Staphylococcus aureus Septicemia. Int J Microbiol (2011) 0.88
P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis. Clin Vaccine Immunol (2010) 0.88
Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations. Antimicrob Agents Chemother (2013) 0.76
Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol (1997) 4.28
Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis (2003) 2.46
Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin Vaccine Immunol (2006) 2.00
Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. Clin Diagn Lab Immunol (2003) 1.38
Defeating pathogen drug resistance: guidance from evolutionary theory. Evolution (2008) 1.18
Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens. Int J Med Microbiol (2008) 1.12
Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations. Clin Diagn Lab Immunol (2004) 1.11
Effective combination therapy for invasive pneumococcal pneumonia with ampicillin and intravenous immunoglobulins in a mouse model. Antimicrob Agents Chemother (2001) 1.09
A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization. Microb Pathog (2007) 1.07
A 28-aa pneumococcal surface adhesin A-derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection. J Infect Dis (2009) 1.00
Monoclonal antibodies come of age. Nature (2008) 0.99
Diagnosis of invasive pneumococcal disease among children in Kenya with enzyme-linked immunosorbent assay for immunoglobulin G antibodies to pneumococcal surface adhesin A. Clin Diagn Lab Immunol (2005) 0.98
Functional antibodies to the O-acetylated pneumococcal serotype 15B capsular polysaccharide have low cross-reactivities with serotype 15C. Clin Vaccine Immunol (2007) 0.97
Immunization in Alzheimer's disease: naïve hope or realistic clinical potential? Mol Psychiatry (2008) 0.93
Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in Kenya. J Infect Dis (2002) 0.93
Prophylaxis and treatment of pneumococcal bacteremia by immune globulin intravenous in a mouse model. Clin Immunol Immunopathol (1989) 0.92
Peripheral immune response in albino rats following cerebroventricular and intraperitoneal antigen challenge. Indian J Physiol Pharmacol (1995) 0.80
The treatment of human immunodeficiency virus infected patients with intravenous immunoglobulin. J Hosp Infect (1988) 0.79
Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol (2007) 4.44
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis (2002) 2.76
Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis (2003) 2.46
Advances in the development of vaccines against Neisseria meningitidis. N Engl J Med (2010) 1.99
Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect Immun (2007) 1.45
Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. Clin Diagn Lab Immunol (2003) 1.38
Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years. J Infect Dis (2010) 1.35
E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae. Microb Pathog (2007) 1.28
Comparison of four polymerase chain reaction assays for specificity in the identification of Streptococcus pneumoniae. Diagn Microbiol Infect Dis (2004) 1.25
Differentiation of Streptococcus pneumoniae conjunctivitis outbreak isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol (2008) 1.16
Standardization and denoising algorithms for mass spectra to classify whole-organism bacterial specimens. Bioinformatics (2004) 1.14
Immunoblot method to detect Streptococcus pneumoniae and identify multiple serotypes from nasopharyngeal secretions. J Clin Microbiol (2004) 1.14
Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002. J Infect Dis (2006) 1.11
Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity. Immun Ageing (2005) 1.09
Interlaboratory comparison of three multiplexed bead-based immunoassays for measuring serum antibodies to pneumococcal polysaccharides. Clin Vaccine Immunol (2010) 1.09
A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization. Microb Pathog (2007) 1.07
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines. Clin Vaccine Immunol (2012) 1.06
Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults. Hum Vaccin (2006) 1.05
Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays. Am J Clin Pathol (2004) 1.04
Pneumococcal surface adhesin A (PsaA): a review. Crit Rev Microbiol (2008) 1.04
Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator. Clin Diagn Lab Immunol (2004) 1.03
SARS surveillance during emergency public health response, United States, March-July 2003. Emerg Infect Dis (2004) 1.03
Development and evaluation of a novel multiplex PCR technology for molecular differential detection of bacterial respiratory disease pathogens. J Clin Microbiol (2008) 1.01
Adherence of nontypeable Streptococcus pneumoniae to human conjunctival epithelial cells. Microb Pathog (2007) 1.01
A 28-aa pneumococcal surface adhesin A-derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection. J Infect Dis (2009) 1.00
Entry and intracellular replication of Mycobacterium tuberculosis in cultured human microvascular endothelial cells. Microb Pathog (2006) 1.00
Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage. Infect Immun (2005) 1.00
Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera. Clin Vaccine Immunol (2010) 0.99
Statistical considerations for vaccine immunogenicity trials. Part 2: Noninferiority and other statistical approaches to vaccine evaluation. Vaccine (2005) 0.99
Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults. Clin Diagn Lab Immunol (2004) 0.98
Adherence of recombinant pneumococcal surface adhesin A (rPsaA)-coated particles to human nasopharyngeal epithelial cells for the evaluation of anti-PsaA functional antibodies. Vaccine (2006) 0.98
Diagnosis of invasive pneumococcal disease among children in Kenya with enzyme-linked immunosorbent assay for immunoglobulin G antibodies to pneumococcal surface adhesin A. Clin Diagn Lab Immunol (2005) 0.98
Functional antibodies to the O-acetylated pneumococcal serotype 15B capsular polysaccharide have low cross-reactivities with serotype 15C. Clin Vaccine Immunol (2007) 0.97
Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies. Clin Diagn Lab Immunol (2003) 0.97
Assignment of additional anticapsular antibody concentrations to the Neisseria meningitidis group A, C, Y, and W-135 meningococcal standard reference serum CDC1992. Clin Diagn Lab Immunol (2002) 0.97
Haemophilus influenzae type a infection and its prevention. Infect Immun (2007) 0.97
CCL5 modulates pneumococcal immunity and carriage. J Immunol (2006) 0.96
Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae. Clin Vaccine Immunol (2006) 0.94
Statistical considerations for vaccine immunogenicity trials. Part 1: Introduction and bioassay design and analysis. Vaccine (2005) 0.94
Antibody responses in postsplenectomy trauma patients receiving the 23-valent pneumococcal polysaccharide vaccine at 14 versus 28 days postoperatively. J Trauma (2002) 0.93
Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States. Antiviral Res (2012) 0.93
Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia. Antimicrob Agents Chemother (2011) 0.92
Avidity determinations for Haemophilus influenzae Type b anti-polyribosylribitol phosphate antibodies. Clin Diagn Lab Immunol (2005) 0.92
Retracted Pneumococcal surface adhesin A (PsaA): a review. Crit Rev Microbiol (2008) 0.92
Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin a. J Infect Dis (2002) 0.91
Fluorescent multivalent opsonophagocytic assay for measurement of functional antibodies to Streptococcus pneumoniae. Clin Diagn Lab Immunol (2005) 0.91
Use of 2 pneumococcal common protein real-time polymerase chain reaction assays in healthy children colonized with Streptococcus pneumoniae. Diagn Microbiol Infect Dis (2011) 0.90
P4-mediated antibody therapy in an acute model of invasive pneumococcal disease. J Infect Dis (2012) 0.90
A Novel Innate Immune-Enhancement Strategy Combined with IVIG Rescues Mice from Fatal Staphylococcus aureus Septicemia. Int J Microbiol (2011) 0.88
P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis. Clin Vaccine Immunol (2010) 0.88
An augmented passive immune therapy to treat fulminant bacterial infections. Recent Pat Antiinfect Drug Discov (2010) 0.87
Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity. Clin Diagn Lab Immunol (2002) 0.87
Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure. Vaccine (2009) 0.86
Evaluation of serum bactericidal antibody assays for Haemophilus influenzae serotype a. Clin Vaccine Immunol (2010) 0.85
Newly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies. Clin Diagn Lab Immunol (2002) 0.85
Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model. Vaccine (2010) 0.83
An in vitro model to assess pneumococcal adherence to nasopharyngeal cells under competition conditions. J Microbiol Methods (2007) 0.81
Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska. Clin Vaccine Immunol (2006) 0.80
A rapid method for capture and identification of immunogenic proteins in Bordetella pertussis enriched membranes fractions: a fast-track strategy applicable to other microorganisms. J Proteomics (2012) 0.80
Measurement of Haemophilus influenzae type a capsular polysaccharide antibodies in cord blood sera. Pediatr Infect Dis J (2012) 0.80
Phenotypic, genomic, and transcriptional characterization of Streptococcus pneumoniae interacting with human pharyngeal cells. BMC Genomics (2013) 0.80